Transcranial Photobiomodulation for Executive Function in Bipolar Disorder

Completed · Phase 2 · Has a placebo group

Conditions studied: Bipolar Disorder

In brief

Transcranial light therapy, or transcranial photobiomodulation (tPBM), is a treatment that stimulates the brain by applying near-infrared light to the forehead. Transcranial light therapy has been found to promote brain metabolism, which may help improve executive function in people with bipolar disorder. The research team proposes a novel approach to treating bipolar disorder by using transcranial light therapy.

Key facts

Study ID
NCT05408637
Run by
Paolo Cassano
People needed
13
Starts
2022-08-09
Expected to finish
2024-05-14
Last updated by the study team
2025-08-28

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.